Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
2,525,199
-
Shares change
-
-211,823
-
Total reported value, excl. options
-
$127,084,457
-
Value change
-
-$10,716,279
-
Number of buys
-
30
-
Number of sells
-
-26
-
Price
-
$50.35
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2021
87 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q1 2021.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,525,199 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (652,773 shares), MORGAN STANLEY (480,358 shares), FACTORY MUTUAL INSURANCE CO (210,000 shares), BANK OF AMERICA CORP /DE/ (173,961 shares), LPL Financial LLC (87,007 shares), JPMORGAN CHASE & CO (85,284 shares), Wharton Business Group, LLC (84,325 shares), Hochman Cole Investment Advisors, Inc. (54,892 shares), HighTower Advisors, LLC (50,027 shares), and WELLS FARGO & COMPANY/MN (48,455 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.